Nimotuzumab
- Generic Name
- Nimotuzumab
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 780758-10-3
- Unique Ingredient Identifier
- 6NS400BXKH
- Indication
Investigated for use/treatment in head and neck cancer, brain cancer, pediatric indications, pancreatic cancer, lung cancer, and colorectal cancer.
- Associated Conditions
- Advanced Head and Neck Cancer, Advanced Stage Head and Neck Cancer, Glioblastoma Multiforme (GBM), High Grade Glioma (HGG), Advanced Epithelial Tumor of the Head and Neck
- Associated Therapies
- -
A Study of Nimotuzumab in Combination With Radiation Therapy in Patients With Brain Metastases
- First Posted Date
- 2009-03-31
- Last Posted Date
- 2011-07-01
- Lead Sponsor
- YM BioSciences
- Target Recruit Count
- 21
- Registration Number
- NCT00872482
- Locations
- 🇺🇸
Florida Cancer Institute - New Hope, New Port Richey, Florida, United States
🇺🇸Park Nicollet Institute - Frauenshuh Cancer Center, St. Louis Park, Minnesota, United States
🇨🇦Cancer Centre for the Southern Interior, Kelowna, British Columbia, Canada
Nimotuzumab in Adults With Glioblastoma Multiforma
- First Posted Date
- 2008-09-16
- Last Posted Date
- 2012-12-03
- Lead Sponsor
- Oncoscience AG
- Target Recruit Count
- 150
- Registration Number
- NCT00753246
- Locations
- 🇩🇪
Dep. Neurosurgery, Univ. Hamburg, Hamburg, Germany
Study of Nimotuzumab and Cisplatin/Radiotherapy for Locally Advanced Head and Neck Squamous Cell Cancer
- Conditions
- Interventions
- First Posted Date
- 2008-06-20
- Last Posted Date
- 2023-02-28
- Lead Sponsor
- National Cancer Centre, Singapore
- Target Recruit Count
- 32
- Registration Number
- NCT00702481
- Locations
- 🇸🇬
National Cancer Center Singapore, Singapore, Singapore
Nimotuzumab in Children With Intrinsic Pontine Glioma
- Conditions
- First Posted Date
- 2007-11-21
- Last Posted Date
- 2013-03-29
- Lead Sponsor
- Oncoscience AG
- Target Recruit Count
- 41
- Registration Number
- NCT00561691
- Locations
- 🇩🇪
University Bonn, Children's Medical Hospital, Bonn, Germany
Nimotuzumab in Adults With Pancreatic Cancer
- First Posted Date
- 2007-11-21
- Last Posted Date
- 2015-10-15
- Lead Sponsor
- Oncoscience AG
- Target Recruit Count
- 188
- Registration Number
- NCT00561990
- Locations
- 🇩🇪
Marienhospital Herne, Herne, Germany
Study of Nimotuzumab and Irinotecan in Metastatic Colorectal Cancer
- Conditions
- Interventions
- First Posted Date
- 2007-06-28
- Last Posted Date
- 2008-11-17
- Lead Sponsor
- YM BioSciences
- Target Recruit Count
- 100
- Registration Number
- NCT00493857
- Locations
- 🇨🇦
Tom Baker Cancer Center, Calgary, Alberta, Canada
🇨🇦Dr. H. Bliss Purphy Cancer Centre, St. John's, Newfoundland and Labrador, Canada
🇨🇦Royal Victoria Hospital, Barrie, Ontario, Canada
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.